标题
The indirect costs of multiple sclerosis: systematic review and meta-analysis
作者
关键词
-
出版物
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 15, Issue 5, Pages 759-786
出版商
Informa UK Limited
发表日期
2016-02-14
DOI
10.1586/14737167.2015.1067141
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland
- (2015) Krzysztof Piotr Malinowski et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet
- (2015) Tracey J. Weiland et al. PLoS One
- ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis
- (2014) Celica Ysrraelit et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Social participation in patients with multiple sclerosis: correlations between disability and economic burden
- (2014) Arnaud Kwiatkowski et al. BMC Neurology
- How to Estimate Productivity Costs in Economic Evaluations
- (2014) Marieke Krol et al. PHARMACOECONOMICS
- The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland
- (2014) P. Mocko et al. VALUE IN HEALTH
- Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Turkey
- (2014) Rana Karabudak et al. JOURNAL OF MEDICAL ECONOMICS
- Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland
- (2014) Emer Fogarty et al. Applied Health Economics and Health Policy
- Costs and quality of life in multiple sclerosis patients with spasticity
- (2013) J. Svensson et al. ACTA NEUROLOGICA SCANDINAVICA
- Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers
- (2013) Hélène Parisé et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases
- (2013) Claire M Rice et al. LANCET
- The economic impact of multiple sclerosis in Australia in 2010
- (2013) Andrew J Palmer et al. Multiple Sclerosis Journal
- Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis
- (2013) Craig I. Coleman et al. PLoS One
- Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands
- (2013) Korinna Karampampa et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments
- (2013) Shekoufeh Nikfar et al. DARU-Journal of Pharmaceutical Sciences
- PND28 Mobility, Indirect Costs, and Health-Related Quality of Life in Multiple Sclerosis
- (2012) C.I. Coleman et al. VALUE IN HEALTH
- PND9 Burden of Multiple Sclerosis (MS) in China
- (2012) S. Hu et al. VALUE IN HEALTH
- PND21 Multiple Sclerosis in Russian Federation: Evaluation of Social and Economical Burden in Real Clinical Practice
- (2012) R. Yagudina et al. VALUE IN HEALTH
- Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US
- (2012) J. I. Ivanova et al. JOURNAL OF MEDICAL ECONOMICS
- Economic Burden in a German Cohort of Patients with Multiple Sclerosis
- (2011) Jens Peter Reese et al. EUROPEAN NEUROLOGY
- The socioeconomic consequences of multiple sclerosis: A controlled national study
- (2011) Poul Jennum et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cost of multiple sclerosis in the Czech Republic: The COMS study
- (2011) J Blahova Dusankova et al. Multiple Sclerosis Journal
- Cost-effectiveness of disease-modifying therapy for multiple sclerosis: A population-based study
- (2011) K. Noyes et al. NEUROLOGY
- PND16 Health Economics of Sclerosis Multiplex in Slovakia
- (2011) M. Psenkova et al. VALUE IN HEALTH
- PND19 Cost Of The Relapse Of Multiple Sclerosis In Spain
- (2011) L. Gubieras et al. VALUE IN HEALTH
- Costos de la Esclerosis Múltiple en Colombia
- (2011) Martin Romero et al. VALUE IN HEALTH
- Comparing costs and absences for multiple sclerosis among US employees: pre- and post-treatment initiation
- (2010) Krithika Rajagopalan et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US
- (2010) Jasmina I. Ivanova et al. PHARMACOECONOMICS
- Economic Burden of Multiple Sclerosis
- (2010) Huseyin Naci et al. PHARMACOECONOMICS
- Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs
- (2009) Howard G. Birnbaum et al. CURRENT MEDICAL RESEARCH AND OPINION
- The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions
- (2009) G Kobelt et al. Multiple Sclerosis Journal
- Multiple Sclerosis in the UK
- (2008) Paul McCrone et al. PHARMACOECONOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started